Literature DB >> 8137350

New techniques in the pharmacokinetic analysis of cancer drugs. II. The ultratrace determination of platinum in biological samples by inductively coupled plasma-mass spectrometry.

K McKay1.   

Abstract

The use of ICP-MS and its various sample introduction techniques has great potential in extending the time scale of study for the pharmacokinetics of platinum containing anti-tumour drugs. Electrothermal vaporization ICP-MS can be used to measure very small samples with very low concentrations. Speciation studies of platinum in tissues can be carried out with HPLC-ICP-MS over longer time periods. Finally, LA-ICP-MS is potentially useful for studying the spatial distribution of platinum in tissues and tumours.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8137350

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  4 in total

1.  Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.

Authors:  Xiang-Hong Peng; Yiqing Wang; Donghai Huang; Yuxiang Wang; Hyung Juc Shin; Zhengjia Chen; Michael B Spewak; Hui Mao; Xu Wang; Ying Wang; Zhuo Georgia Chen; Shuming Nie; Dong M Shin
Journal:  ACS Nano       Date:  2011-11-04       Impact factor: 15.881

2.  Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.

Authors:  A Johnsson; C Olsson; O Nygren; M Nilsson; B Seiving; E Cavallin-Stahl
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 3.  Matrix-assisted laser desorption/ionization imaging mass spectrometry.

Authors:  Nobuhiro Zaima; Takahiro Hayasaka; Naoko Goto-Inoue; Mitsutoshi Setou
Journal:  Int J Mol Sci       Date:  2010-12-07       Impact factor: 5.923

4.  Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells.

Authors:  Salma El-Shafie; Sherif Ashraf Fahmy; Laila Ziko; Nada Elzahed; Tamer Shoeib; Andreas Kakarougkas
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.